ATC level 4
L01EACancer medicines (antineoplastics), subgroup L01E, subgroup L01EA
- Molecules
- 6
- Subgroups
- 6
ATC L01EA (Cancer medicines (antineoplastics), subgroup L01E, subgroup L01EA) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 6 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under L01EA.
- AsciminibOrphan3 presentations2 brandsL01EA06
- BosutinibOrphanKinase Inhibitor8 presentations2 brandsL01EA04
- DasatinibOrphanKinase Inhibitor18 presentations4 brandsL01EA02
- ImatinibOrphanKinase Inhibitor5 presentations5 brandsL01EA01
- NilotinibOrphanKinase Inhibitor10 presentations5 brandsL01EA03
- PonatinibOrphanKinase Inhibitor4 presentations2 brandsL01EA05
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.